EGFR and head and neck squamous cell carcinoma: HPV-related SCCHN is known to be more sensitive to cytotoxic chemotherapy and radiation therapy [45], and the efficacy of anti-EGFR therapy is also more prominent in HPV-related SCCHN patients [46, 47].